Pfizer (PFE) has agreed to pay closely held Bind Therapeutics up to $210M to use the latter's...

|About: Pfizer Inc. (PFE)|By:, SA News Editor

Pfizer (PFE) has agreed to pay closely held Bind Therapeutics up to $210M to use the latter's nanotechnology to develop medicines. Bind's nanoparticles, called Accurins, can transport drugs through the body and home in on diseased cells without harming healthy tissue. Bind's technology has the potential to be used to treat cancer, inflammatory ailments and cardiovascular disorders. (PR)